Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver (clinicaltrials.gov) - Oct 24, 2026 - P=N/A | N=20 | Recruiting | Sponsor: Massachusetts General Hospital | N=10 ➔ 20
Enrollment change • Eye Cancer • Melanoma • Ocular Melanoma • Oncology • Solid Tumor • Uveal Melanoma
|